A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan
Nolan M. Winicki(University of California San Diego), Edward G. Lakatta(Johns Hopkins University), Alay Nanavati(National Institute on Aging), Michael Brines(Northwell Health), Rafael de Cabo(National Institute on Aging), Steven J. Sollott(National Institute on Aging), Daniel R. Riordon(National Institutes of Health), Christopher E. Ramirez(National Institute on Aging), Christopher H. Morrell(Loyola University Maryland), Irene Alfaras(National Institute on Aging), Max G. Beyman(National Institute on Aging), Mingyi Wang(Chinese PLA General Hospital), Jessie Axsom(California University of Pennsylvania), Sarah J. Mitchell(Princeton University), Jack M. Moen(Yale University), Natalia Petrashevskaya(National Institute on Aging), Magdalena Juhaszova(Institute on Aging), Melissa Krawczyk(National Institute on Aging), Jing Zhang(Yanshan University), Anthony Cerami(Araim Pharmaceuticals (United States))
Cited by 3
Related Papers
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
|Science|2012|1.7k
<p>The Antibacterial Mechanism of Silver Nanoparticles and Its Application in Dentistry</p>
|International Journal of Nanomedicine|2020|1.6k
Erythropoietin crosses the blood–brain barrier to protect against experimental brain injury
|Proceedings of the National Academy of Sciences|2000|1.4k
Elevated Aortic Pulse Wave Velocity, a Marker of Arterial Stiffness, Predicts Cardiovascular Events in Well-Functioning Older Adults
|Circulation|2005|1.2k
Arterial and Cardiac Aging: Major Shareholders in Cardiovascular Disease Enterprises
|Circulation|2003|1.1k